Jessica D. Johnson is a dedicated integrated biomedical scientist and PhD candidate specializing in cancer biology at UT Health San Antonio. She obtained her Bachelor’s degree from the University of Georgia, majoring in pharmaceutical science and biological sciences. Currently, her research focuses on uncovering the role of epigenetic modifiers in ovarian cancer and breast cancer brain metastases, aiming to develop effective treatment options for patients facing this challenging condition. Her career aspirations lie in drug development, clinical trials, and data science, where she intends to leverage her expertise to drive innovative approaches for cancer treatment through a data-driven process, ensuring the efficacy of newly developed therapeutics. Jessica’s passion for unraveling novel concepts drives her commitment to enhancing prevention interventions and pushing the boundaries of cutting-edge therapeutics, contributing significantly to the field’s understanding of cancer in a patient-centric manner.